Incyte Corporation Revenue 2009–2025
Incyte Corporation annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Incyte Corporation revenue for the quarter ending March 31, 2026 was 1.3 B, a 20.87% increase year-over-year.
- Incyte Corporation revenue for the twelve months ending March 31, 2026 was 4.9 B, a 23.25% increase year-over-year.
- Incyte Corporation annual revenue for 2025 was 5.1 B, a 21.22% increase from 2024.
- Incyte Corporation annual revenue for 2024 was 4.2 B, a 14.76% increase from 2023.
- Incyte Corporation annual revenue for 2023 was 3.7 B, a 8.87% increase from 2022.
- Incyte Corporation annual revenue for 2022 was 3.4 B.
Incyte Corporation (INCY) — Frequently Asked Questions
Incyte Corporation (INCY) is a publicly traded US company. It has a market capitalization of $21.83B. In fiscal 2025 it reported revenue of $5.14B and net income of $1.29B. Explore INCY's stock price, financial statements, earnings history, margins and key ratios below.
What is Incyte Corporation's market cap?
Incyte Corporation (INCY) has a market capitalization of $21.83B.
What is the INCY stock price?
INCY trades at $108.77 (+3.20% on the day).
How much revenue does Incyte Corporation make?
Incyte Corporation reported revenue of $5.14B in fiscal 2025.
Is INCY profitable?
In fiscal 2025, Incyte Corporation reported net income of $1.29B.